MediPharm Labs Corp.
MEDIF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10,694 | -$13,083 | -$29,983 | -$54,801 |
| Dep. & Amort. | $2,600 | $2,516 | $2,872 | $5,633 |
| Deferred Tax | $0 | -$2,691 | -$6 | $113 |
| Stock-Based Comp. | $976 | $2,027 | $2,872 | $2,402 |
| Change in WC | $1,652 | $3,450 | $6,245 | $21,828 |
| Other Non-Cash | $605 | -$3,982 | $1,931 | $11,612 |
| Operating Cash Flow | -$4,861 | -$11,763 | -$16,069 | -$13,213 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$154 | -$471 | -$863 | -$783 |
| Net Acquisitions | $0 | $7,343 | $6,014 | $818 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $567 | $1,903 | $7 | $507 |
| Investing Cash Flow | $413 | $6,872 | $5,158 | $35 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,252 | -$944 | $393 | -$2,962 |
| Stock Issued | $0 | $0 | $0 | $30,917 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $405 | $576 | $403 | -$151 |
| Financing Cash Flow | -$1,847 | -$944 | $796 | $27,804 |
| Forex Effect | $4 | -$329 | $150 | -$429 |
| Net Chg. in Cash | -$6,291 | -$6,164 | -$9,965 | $14,197 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $17,981 | $24,145 | $34,110 | $19,913 |
| End Cash | $11,690 | $17,981 | $24,145 | $34,110 |
| Free Cash Flow | -$5,015 | -$12,234 | -$16,932 | -$13,996 |